Print Page | Close Window

Investor FAQs

Q: Where is Tokai Pharmaceuticals headquartered?

A: Tokai is headquartered at 225 State Street, 6th Floor, Boston, MA 02109. The main phone number is (617) 225-4305.

Q: When was Tokai Pharmaceuticals founded?

A: Tokai was incorporated in 2004 in the state of Delaware.

Q: How is Tokai Pharmaceuticals’ stock traded?

A: Tokai is traded on the NASDAQ Global Market under the ticker symbol TKAI and its CUSIP number is 88907J 107.

Q: How can I purchase shares of Tokai Pharmaceuticals' stock?

A: Shares of TKAI can be purchased through a stockbroker of your choice.

Q: When is Tokai Pharmaceuticals’ fiscal year-end?

A: December 31st.

Q: Who is the transfer agent for Tokai Pharmaceuticals?

A: Continental Stock Transfer & Trust
Phone: (212) 845-3224
17 Battery Place, 8th Floor
New York, NY 10004
http://www.continentalstock.com/contact/

Q: Who is Tokai Pharmaceuticals’ independent auditor?

A: PricewaterhouseCoopers, LLP
125 High Street
Boston, MA 02110
(617) 530-5000

Q: Where can I view Tokai Pharmaceuticals’ corporate news releases?

A: Tokai’s press release archives can be accessed in the Press Releases section.

Q: Where can I view documents that Tokai Pharmaceuticals has filed with the Securities & Exchange Commission (SEC)?

A: Tokai’s SEC filings can be accessed in the SEC Filings section of the site or www.sec.gov.

Q: Who should I contact if I have further questions?

A: You can submit queries to Tokai’s investor relations department by contacting investors@tokaipharma.com.